Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

A John Orwin

Affiliations

  • Director at Array Biopharma Inc (ARRY), 2019-07-31
  • President & Ceo at Atreca Inc. (BCEL), 2019-06-19
  • Director at Seattle Genetics Inc (SGEN), 2019-05-23
  • Director at Retrophin Inc. (RTRX), 2019-05-11
  • President & Ceo at Relypsa Inc (RLYP), 2016-09-02
  • Director at Affymax Inc (AFFY), 2013-06-28
  • Director at Neurogesx Inc (NGSX), 2012-06-12
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SGEN $28.33 2,000 Director 10,700 2016-02-12 Filing
RLYP $11.00 15,000 Officer, Director 15,000 2013-11-20 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RLYP $29.67 800 Officer, Director 54,375 2015-12-07 Filing
RLYP $28.52 7,379 Officer, Director 55,175 2015-12-07 Filing
RLYP $27.85 6,821 Officer, Director 62,554 2015-12-07 Filing
RLYP $25.00 20,000 Officer, Director 59,375 2015-12-04 Filing
RLYP $25.00 20,000 Officer, Director 59,375 2015-12-02 Filing